News | July 29, 2011

iCad Highlights Xoft Electronic Brachytherapy System at Key Industry Conference

July 29, 2011iCAD will highlight its Xoft Axxent eBx electronic brachytherapy system at the 2011 Joint American Association of Physicists in Medicine (AAPM)/ Canadian Organization of Medical Physicists (COMP) meeting in Vancouver, British Columbia, this weekend.

At the show, iCAD will present a poster discussing dosimetry measurements for a new applicator under development for use with the Xoft system. The new interstitial applicator would enable the delivery of Xoft eBx therapy to patients who need very localized radiation delivery, such as those with spinal metastases. Authors will present at the General Poster session on Sunday, July 31 from 3:00 p.m. to 6:00 p.m. in the General Poster Area of Exhibit Hall C.

In addition, several clinicians and scientists specializing in radiation therapy and dosimetry will present information on applications for the Axxent eBx system, including its use for Intraoperative Radiation Therapy (IORT) and fundamental X-ray source calibration developments, at the “Advances in eBx” Luncheon Symposium at 12:30 p.m. on August 2, in West Wing Rooms 202-204 at the Vancouver Convention Centre.

The Axxent system uses a proprietary isotope-free miniaturized X-ray source to deliver radiation in minimally shielded environments directly to the cancerous tumor bed. The Axxent system is approved for accelerated partial breast irradiation (APBI), which can be delivered twice daily for five days, or it can be administered immediately following the lumpectomy procedure in only a few minutes with one course of therapy, also known as intraoperative radiation therapy (IORT). The system is cleared by the U.S. Food and Drug Administration (FDA) for treatment of conditions where radiation is indicated, including early stage breast cancer, skin cancer and endometrial cancer. 

iCAD recently received clearance from the FDA for its new Axxent Rigid Shield, a stainless steel shielding device to protect tissue and/or organs from radiation. The Rigid Shield is intended to be used internally, such as during IORT procedures when the treatment site is surgically exposed and provides surgeons and radiation oncologists another option for shielding patients from unnecessary radiation exposure.

In addition to the Xoft system, iCAD will also showcase its magnetic resonance imaging (MRI) suite of advanced image analysis solutions, including: VividLook, SpectraLook, OmniLook, PrecisionPoint and VersaVue Enterprise, which are designed to improve accuracy for the detection of cancers and provide clinicians with objective localization, staging, treatment planning and serial monitoring.

iCAD will be at the 2011 Joint American Association of Physicists in Medicine (AAPM)/ Canadian Organization of Medical Physicists (COMP) meeting from July 31 – August 4, 2011, in booth # 1130.

For more information: www.icadmed.com

 

Related Content

Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018
Varian announced it will be showcasing its advanced cancer care solutions, including a new version of the Eclipse...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
News | Brachytherapy Systems, Women's Healthcare | December 19, 2017
iCAD Inc. announced the results of a landmark study that showed the benefits of adjunct intraoperative radiation...
Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Overlay Init